Oncopeptides AB Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 29, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	76	29	65	103	62	1,148
Market Cap Growth	204.93%	-55.17%	-36.62%	67.24%	-94.64%	71.09%
Enterprise Value	76	18	54	65	-4	1,024
Last Close Price	0.28	0.12	0.46	0.72	0.50	11.18
PS Ratio	13.47	10.58	20.58	137.15	5.35	-
PB Ratio	128.69	6.17	12.76	3.89	3.00	19.99
P/TBV Ratio	128.69	6.17	12.76	3.89	3.02	20.05
EV/Sales Ratio	12.85	6.38	17.01	86.70	-	-
Debt / Equity Ratio	22.75	2.61	2.31	0.02	0.07	0.03
Asset Turnover	0.24	0.13	0.11	0.02	0.17	-
Inventory Turnover	0.21	0.78	-	-	-	-
Quick Ratio	3.27	3.74	4.26	4.22	1.78	2.44
Current Ratio	3.42	4.23	4.52	4.25	1.83	2.53
Return on Equity (ROE)	-376.73%	-512.51%	-141.91%	-133.80%	-363.13%	-232.14%
Return on Assets (ROA)	-57.86%	-73.20%	-50.66%	-52.59%	-134.59%	-97.95%
Return on Capital Employed (ROCE)	-158.10%	-146.50%	-130.70%	-115.80%	-697.10%	-256.70%
Earnings Yield	-31.83%	-85.00%	-34.38%	-29.49%	-226.15%	-13.83%
FCF Yield	-27.13%	-77.93%	-38.59%	-36.92%	-239.82%	-11.39%
Buyback Yield / Dilution	-58.45%	-84.14%	-9.80%	-9.33%	-20.72%	-20.63%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.